Testing effectiveness (Phase 2)Study completedNCT00464516What this trial is testingPreoperative Estetrol in Breast CancerWho this might be right forBreast Cancer Pantarhei Bioscience 30
Large-scale testing (Phase 3)Ended earlyNCT01548534What this trial is testingA Randomised Study of Docosahexaenoic Acid (DHA) in Metastatic Breast CancerWho this might be right forMetastatic Breast CancerProgesterone Receptor Positive TumorEstrogen Receptor Positive Tumor+1 more University Hospital, Tours 65
Testing effectiveness (Phase 2)Active Not RecruitingNCT03366844What this trial is testingBreast Cancer Study of Preoperative Pembrolizumab + RadiationWho this might be right forBreast Cancer Stephen Shiao 66
Not applicableStudy completedNCT04246606What this trial is testingConcordance of the IHC4 Score Performed in Local or Central Laboratory to Endopredict in ER+/HER2- Breast CancerWho this might be right forBreast Neoplasm Female UNICANCER 155
Early research (Phase 1)Active Not RecruitingNCT05463952What this trial is testingLearn About the Vepdegestrant (ARV-471, PF-07850327) in People With ER+/HER2- Locally Advanced or Metastatic Breast Cancer (BC)Who this might be right forBreast Neoplasms Pfizer 6
Large-scale testing (Phase 3)Looking for participantsNCT04601116What this trial is testingThe MASTER Study (MAmmary Cancer STatin ER Positive Study)Who this might be right forBreast Cancer FemaleEstrogen Receptor Positive Tumor Aarhus University Hospital 3,360
Early research (Phase 1)Active Not RecruitingNCT06533059What this trial is testingLearn About Study Medicine ALTA2618 in Adults With AKT1 E17K-Mutant Solid TumorsWho this might be right forCancerBreast CancerEndometrial Cancer+2 more Alterome Therapeutics, Inc. 110
Not applicableLooking for participantsNCT06127979What this trial is testingChanges in Ki67 Expression in People With Breast Cancer Receiving Endocrine Therapy Before SurgeryWho this might be right forBreast Cancer Memorial Sloan Kettering Cancer Center 42
Testing effectiveness (Phase 2)Looking for participantsNCT06452394What this trial is testingNEODOXy: Targeting Breast Cancer Stem Cells With DoxycyclineWho this might be right forBreast Cancer Swiss Cancer Institute 50
Large-scale testing (Phase 3)UnknownNCT01104571What this trial is testingTrastuzumab or Lapatinib Ditosylate in Treating Women With Early Breast CancerWho this might be right forBreast Cancer Institute of Cancer Research, United Kingdom 257
Testing effectiveness (Phase 2)Looking for participantsNCT06062498What this trial is testingElacestrant vs Elacestrant Plus a CDK4/6 Inhibitor in Patients With ERpositive/HER2-negative Advanced or Metastatic Breast CancerWho this might be right forEstrogen-receptor-positive Breast CancerHER2/Neu-Negative Breast CancerAdvanced Breast Cancerv+1 more Northwestern University 174
Early research (Phase 1)Study completedNCT03554044What this trial is testingT-VEC With Chemotherapy or Endocrine Therapy in Treating Participants With HER2- Negative Breast CancerWho this might be right forAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+11 more University of California, San Francisco 20
Testing effectiveness (Phase 2)WithdrawnNCT02115594What this trial is testingPhase 2 Study of Fulvestrant With and Without Entinostat in Postmenopausal Women With ER+ Advanced Breast CancerWho this might be right forBreast Cancer Syndax Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT01074970What this trial is testingPARP Inhibition for Triple Negative Breast Cancer (ER-/PR-/HER2-)With BRCA1/2 MutationsWho this might be right forBreast Cancer Hoosier Cancer Research Network 135
Testing effectiveness (Phase 2)Ended earlyNCT01207102What this trial is testingStudy Of Abraxane® And Carboplatin As First-Line Treatment For Triple Negative Metastatic Breast CancerWho this might be right forMetastatic Breast Cancer Duke University 10
Testing effectiveness (Phase 2)Study completedNCT03078751What this trial is testingAdjuvant Ribociclib With Endocrine Therapy in Hormone Receptor+/HER2- High Risk Early Breast CancerWho this might be right forBreast Cancer Novartis Pharmaceuticals 54
Large-scale testing (Phase 3)Study completedNCT03778931What this trial is testingPhase 3 Trial of Elacestrant Versus Standard of Care for the Treatment of ER+/HER2- Advanced Breast CancerWho this might be right forBreast Cancer Stemline Therapeutics, Inc. 478
Early research (Phase 1)Study completedNCT01770353What this trial is testingMM-398 (Nanoliposomal Irinotecan, Nal-IRI) to Determine Tumor Drug Levels and to Evaluate the Feasibility of Ferumoxytol Magnetic Resonance Imaging to Measure Tumor Associated Macrophages and to Predict Patient Response to TreatmentWho this might be right forSolid TumorsER/PR Positive Breast CancerTriple Negative Breast Cancer+1 more Ipsen 45
Testing effectiveness (Phase 2)Study completedNCT05889728What this trial is testingPilot Trial to Assess 68Ga Bombesin PET/CT (NeoB) Imaging for Staging of Breast CancerWho this might be right forBreast Cancer St Vincent's Hospital, Sydney 20
Not applicableUnknownNCT05613270What this trial is testingCharacterizing Breast Cancer With 18F-FES PET/CTWho this might be right forBreast Cancer Peking Union Medical College Hospital 50